Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph Ross, MD, MHS
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Birmingham
Birmingham, Alabama, United States
- Cedars Sinai
Los Angeles, California, United States
- Yale-New Haven Health
New Haven, Connecticut, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Monument Health
Rapid City, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2020
- Primary completion
- 30 Nov 2023
- Completion
- 30 Nov 2023
- Last update posted
- 5 Dec 2023
- Registered enrollment
- 1,709
- Registry id
- NCT04509115
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.